Results 121 to 130 of about 35,110 (238)

Recurrent aggressive chondrosarcoma of the middle phalanx of the index finger: excision and reconstruction with an osteocartilaginous allograft [PDF]

, 2018
Introduction: Chondrosarcomas are malignant tumours and need to be treated aggressively including ablative surgery. Bovée et al. and Mankin have recently drawn attention to a less aggressive behaviour of chondrosarcomas of the phalanges compared with ...
Dumont, Charles, Exner, G., Malinin, Theodore, von Hochstetter, Arthur   +3 more
core  

Histopathologic Differentiation between Enchondroma and Well-differentiated Chondrosarcoma: Evaluating the Efficacy of Diagnostic Histologic Structures

Journal of Dental Research, Dental Clinics, Dental Prospects, 2011
Background and aims. Well-differentiated chondrosarcoma and enchondroma are similar in histopathologic aspects; therefore, special methods should be used to make a distinction between these benign and malignant tumors.
Shams Shariat Torbaghan, Mahdi Ashouri, Noushin Jalayer Naderi, Nima Baherini   +3 more
doaj  

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. [PDF]

, 2018
BackgroundNew prognostic markers are needed to identify patients with Ewing sarcoma (EWS) and osteosarcoma unlikely to benefit from standard therapy.
Barkauskas, Donald A, Clapp, Andrea, Crompton, Brian D, DuBois, Steven G, Gorlick, Richard, Ha, Gavin, Hall, David, Imamovic-Tuco, Alma, Janeway, Katherine A, Klega, Kelly, Krailo, Mark D, Leavey, Patrick J, Lessnick, Stephen L, London, Wendy B, Mascarenhas, Leo, Nag, Anwesha, Shulman, David S, Stegmaier, Kimberly, Thorner, Aaron R, Van Allen, Eliezer, Vo, Kieuhoa T   +20 more
core   +1 more source

Chondrosarcoma, A 30 Year Retrospective Study in Cancer Institute Imam Khomeini Hospital and Faculty of Dentistry of Tehran University of Medical Sciences

Frontiers in Dentistry, 2004
Statement of Problem: Chondrosarcoma is a tumor which includes 10 percent of the bone primary tumors. Its prevalence is half of the osteosarcoma and two times of Ewing’s. The mean age of the patients ranges between 30-50 years of old.
N. Eshghyar; Mohebbi
doaj  

Laryngeal Chondrosarcoma [PDF]

Ear, Nose & Throat Journal, 2018
Norman J, Chan, Christopher, Fundakowski, Ahmed M, Soliman   +2 more
openaire   +2 more sources

Mesenchymal Chondrosarcoma of the Mandible, a Big Dilemma: Report of a Rare Case in Mesenchymal Chondrosarcoma of the Mandible—Report of a Case With Discussion of Diagnostic and Therapeutic Dilemmas

Case Reports in Dentistry
Chondrosarcomas are a group of malignant neoplasms with cartilaginous matrix production mostly found in flat and peripheral long bones. Mesenchymal chondrosarcoma is one of the most unusual and rare histological variants of chondrosarcoma, with a ...
Abbas Karimi, Samira Derakhshan, Farzaneh Mosavat, Zahra Gholamhoseini, Monir Moradzadeh Khiavi   +4 more
doaj   +1 more source

Factores pronósticos en el tratamiento del condrosarcoma [PDF]

, 1991
Los autores 30 condrosarcomas tratados en su Departamento. Estudiando la distribución por sexos, edad, localización, supervivencia y los factores pronósticos respecto a la relación entre el tipo histológico, localización, tratamiento, origen y tiempo ...
Cara del Rosal, José Antonio, Cañadell Carafí, José, Laclériga Giménez, A.F., Losada, J. I.   +3 more
core  

miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism

Drug Design, Development and Therapy, 2016
Xian-ye Tang,1,2,* Wei Zheng,1,2,* Min Ding,3 Kai-jin Guo,1,2 Feng Yuan,1 Hu Feng,1 Bin Deng,1 Wei Sun,1 Yang Hou,4 Lu Gao5,6 1Department of Orthopedic, The First Clinical Medical College, Nanjing Medical University, Nanjing, 2Affiliated Hospital of ...
Tang XY, Zheng W, Ding M, Guo KJ, Yuan F, Feng H, Deng B, Sun W, Hou Y, Gao L   +9 more
doaj  

Isocitrate dehydrogenase mutations as potential tumour agnostic targets. [PDF]

EJC Suppl
Macarulla T, Tabatabai G, Stacchiotti S, Bridgewater J.   +3 more
europepmc   +1 more source

Characteristics, treatment and survival of patients with chondrosarcoma in five European countries: a DARWIN EU® cohort study. [PDF]

Acta Oncol
Barchuk A, Barboza C, Politi J, Raventós B, Prinsen P, Evers J, Ho VK, Van de Sande MA, Fey E, Porkka K, Hammais A, Wahlfors T, Nieminen T, Lehtonen T, Delmestri A, Verdy G, Griffier R, De Burgos-González A, Llorente-Garcia A, Justo-Astorgano C, Macia-Martinez MA, Tenhunen O, Schiel A, Pacurariu A, Brennan R, Williams R, Verhamme K, Duarte Salles T.   +27 more
europepmc   +1 more source